DAVIDE MARIA FERRARIS

DAVIDE MARIA FERRARIS is an Associate Professor in the Department of Pharmaceutical Sciences at Università degli Studi del Piemonte Orientale Amedeo Avogadro. His research focuses on structural biology, enzymology, and drug discovery targeting infectious diseases (e.g., Mycobacterium tuberculosis) and cancer. Key areas include enzyme-inhibitor interactions, antiviral therapies, and protein structure-function relationships.

He leads several projects:

• PROSTAMET (2024-2027): Developing prostate cancer therapies targeting lipid metabolism.
• DIRECT (2023-2025): Designing broad-spectrum antivirals against coronaviruses.
• Leukemia drug development (2019-2022): Focusing on DHODH inhibitors.
• Glioblastoma diagnostic probes (2017-2019): ALDH1A3-targeted fluorescent agents.

Research interests span:

• Mycobacterial pathogenesis and drug targets.
• Structural insights into human enzymes (e.g., DHODH, ALDH1A3).
• Host-pathogen interactions and antiviral strategies.

Recent articles highlight AI-driven drug screening, MET receptor activation mechanisms, and enzyme-based therapeutic development. Collaborations span global institutions in structural biology and medicinal chemistry.